Next era of disease modeling

In drug discovery and disease research, primary cell models are essential for accurately mimicking human biology, offering a more physiologically relevant alternative to traditional cell lines and animal models. Preci’s solutions go beyond providing advanced ECM scaffolds by focusing on overcoming key challenges in primary cell modeling, such as donor-to-donor variability and scalability. Preci’s innovative microfluidic spheroid generation technology addresses these challenges by producing highly homogeneous spheroids with a precisely controlled number of cells. This high-throughput process can generate over 5,000 microspheres per hour, enabling reliable, reproducible models that better reflect human disease mechanisms and drug responses. By enhancing the precision and scalability of primary cell models, Preci helps bridge the gap between preclinical studies and clinical outcomes, ultimately supporting the development of safer, more effective therapeutics.With these powerful tools, Preci enables researchers to optimize their studies and achieve more accurate predictions of drug efficacy, toxicity, and metabolism, driving innovation and efficiency in drug discovery and disease research.